Asana Biosciences To Present Preclinical Data For A Novel Dual Inhibitor Of SYK And JAK Family Kinases And A 5T4-Targeted Antibody Drug Conjugate At The American Association for Cancer Research Annual Meeting In Philadelphia, April 18-22, 2015

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Asana BioSciences, LLC today announced that it will be presenting preclinical data regarding two of its lead molecules at the American Association for Cancer Research (AACR) Annual Meeting being held in Philadelphia, April 18-22, 2015. The presentation details are as follows:

Help employers find you! Check out all the jobs and post your resume.